Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melhem Solh

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Blood Advances|July 5, 2022
Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 studyJuan P Alderuccio, Weiyun Z Ai, John Radford, et al.
The Lancet. Oncology|May 14, 2021
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trialPaolo F Caimi, Weiyun Ai, Juan Pablo Alderuccio, et al.
Blood Advances|October 23, 2023
Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trialMehdi Hamadani, Alexander Spira, Xiaolei Zhou, et al.
Blood Advances|February 15, 2018
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamideShannon R McCurdy, Mei-Jie Zhang, Andrew St Martin, et al.
Nature Medicine|October 2, 2023
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trialNizar J Bahlis, Caitlin L Costello, Noopur S Raje, et al.
Blood Cancer Journal|April 30, 2021
Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Blood Advances|February 12, 2021
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donorsMichael R Grunwald, Mei-Jie Zhang, Hany Elmariah, et al.
Blood Cancer Journal|December 5, 2019
Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
American Journal of Hematology|August 11, 2025
CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR AnalysisJordan Gauthier, Kwang W Ahn, Jinalben Patel, et al.
The Lancet. Haematology|July 30, 2022
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trialAmy E DeZern, Mary Eapen, Juan Wu, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Blood Advances|July 5, 2022
Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 studyJuan P Alderuccio, Weiyun Z Ai, John Radford, et al.
The Lancet. Oncology|May 14, 2021
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trialPaolo F Caimi, Weiyun Ai, Juan Pablo Alderuccio, et al.
Blood Advances|October 23, 2023
Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trialMehdi Hamadani, Alexander Spira, Xiaolei Zhou, et al.
Blood Advances|February 15, 2018
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamideShannon R McCurdy, Mei-Jie Zhang, Andrew St Martin, et al.
Nature Medicine|October 2, 2023
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trialNizar J Bahlis, Caitlin L Costello, Noopur S Raje, et al.
Blood Cancer Journal|April 30, 2021
Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Blood Advances|February 12, 2021
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donorsMichael R Grunwald, Mei-Jie Zhang, Hany Elmariah, et al.
Blood Cancer Journal|December 5, 2019
Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
American Journal of Hematology|August 11, 2025
CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR AnalysisJordan Gauthier, Kwang W Ahn, Jinalben Patel, et al.
The Lancet. Haematology|July 30, 2022
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trialAmy E DeZern, Mary Eapen, Juan Wu, et al.
Pageof 11